PharmaCyte Biotech
Manufacturing · Nevada, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3960 Howard Hughes Pkwy Ste 500, Las Veg...Phone Number
(917) 595-2850Website
www.pharmacyte.comRevenue
<$5 MillionStock Symbol
PMCBIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About PharmaCyte Biotech
PharmaCyte Biotech, Inc. is a biotechnology company based in Las Vegas, Nevada, focused on developing and commercializing cellular therapies for cancer and diabetes in the United States. The company utilizes Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology, to create therapies for various cancers, including advanced pancreatic cancer, and for diabetes. PharmaCyte is also exploring therapies for Type 1 and insulin-dependent Type 2 diabetes, as well as cancer treatments based on cannabis plant constituents. Originally known as Nuvilex, Inc., the company rebranded as PharmaCyte Biotech, Inc. in 2015.Explore more
PharmaCyte Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PharmaCyte Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on PharmaCyte Biotech recently announced quarterly report
Check if PharmaCyte Biotech has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when PharmaCyte Biotech launches new products
PharmaCyte Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if PharmaCyte Biotech had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at PharmaCyte Biotech
Funding: Get notified immidiatlly once PharmaCyte Biotech has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if PharmaCyte Biotech is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined PharmaCyte Biotech as Masked Content
Find more new buyers
Compare Similar Companies to PharmaCyte Biotech
Compare insights from companies similar to PharmaCyte Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PharmaCyte Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PharmaCyte Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PharmaCyte Biotech.
PharmaCyte Biotech financials insights
Gather financial insights about PharmaCyte Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Private Equity
$7M
PharmaCyte Biotech Tech Stack
A closer look at the technologies used by PharmaCyte Biotech
Most Recent Scoops
Funding
Funding
Earnings
Project
Search, Medical Research, Healthcare Technology
Earnings
Pain Point
Pain Point, Funding, Intellectual Property, Logistics / Supply Chain, Barriers, Clinical Operations, Finance, Manufacturing Operations, Operations, Regulations, Risk
Earnings
Product Development, Data Management, Product Management, Search, Logistics / Supply Chain, Medical Research, Clinical Operations, Finance, Manufacturing Operations, Marketing Relationships, Operations, Risk
Earnings
Search, Medical Research
PharmaCyte Biotech News & Media
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position ...
PharmaCyte Biotech, Inc. today announced the successful monetization of its stake in Femasys Inc. further validating the Company’s strategic approach to capital deployment and strengthening its already solid financial position. Following the monetization of the stake, PharmaCyte’s cash and marketable securities are expected to increase to approximately $20 million, up from $13.3 million as of July 31, 2025. This ...PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors
Biotech firm raises $7M through convertible preferred stock at $1.00/share with 7% dividend. Deal includes warrants for 7M shares. Financing strengthens balance sheet for strategic alternatives.MyMD Pharmaceuticals Secures Strategic Investments
BALTIMORE--(BUSINESS WIRE)---- $MYMD--MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, and autoimmune and inflammatory conditions, today announced that it has secured $7 million in commitments in two private placement funding rounds led by a strategic investor, PharmaCyte Biotech, Inc. (Nasdaq: PMCB), a clinical-stage biotechnology company developing cellular therapiePharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”), today announced a $7 million investment in MyMD Pharmaceuticals, Inc. (Nasdaq:MYMD) (“MyMD”) a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, autoimmune and inflammatory conditions. MyMD has announced positive data for a 40-patient Phase 2 clinical trial for its lead product, MYMD-1 in sarcopenia, and is moving its clinical program forw
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PharmaCyte Biotech
Sign Up For FreeTo access detailed company insights
PharmaCyte Biotech, Inc. is a biotechnology company based in Las Vegas, Nevada, focused on developing and commercializing cellular therapies for cancer and diabetes in the United States. The company utilizes Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology, to create therapies for various cancers, including advanced p... Read More
